Condition 1: Burning. Condition 2: Burning. Condition 3: Burning. Burns of multiple regions, at least one burn of third degree mentioned Burn of second degree, body region unspecified Burn of third degree, body region unspecified
Conditions
Interventions
Treatment - Drugs
Intervention 1: Intervention group: Graft donor site dressing consists of Melolin and Flexigrid. Melolin: Manufactured by Smith and Nephew Wound Management Factory, free from adherence to the wound,
Intervention group: Graft donor site dressing consists of Melolin and Flexigrid. Melolin: Manufactured by Smith and Nephew Wound Management Factory, free from adherence to the wound, size 10 cm× 20
Control group: Graft donor site dressing is Fine Mesh Gauze. Fine mesh gauze is sterile and less adherent to the wound surface. This dressing can be dipped in a medicated solution or covered with an a
Sponsors
Vice chancellor for research, Birjand University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: (1) Burn wounds which require partial thickness skin graft (2) Age 15 to 35 years (3) Burn surface area 20% to 50%. Exclusion criteria: (1) Background disease which interferes with wound healing (2) Drug history which interferes with wound healing (steroids and chemotherapy) (3) Chemical or electrical burns
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wound epithelialization time. Timepoint: Wound epithelialization time will be measured daily since the start of the intervention. Method of measurement: Wound epithelialization time will be measured by inspection by one expert surgeon.;The final "cost". Timepoint: At the end of intervention. Method of measurement: The final "cost" will be measured at the end of the intervention on RLS.;Donor site "infection". Timepoint: Donor site "infection" will be measured daily since the start of intervention. Method of measurement: Donor site "infection" will be measured by wound appearance (erythema, warmth and pussy exudates), smear and culture.;"Pain" at the time of dressing change. Timepoint: At the time of dressing change. Method of measurement: "Pain" at the time of dressing change will be measured by the pain reported by patient (given a score between 0 and 10). | — |
Secondary
| Measure | Time frame |
|---|---|
| Scar. Timepoint: One month after hospital discharge. Method of measurement: Scar of graft donor site wound will be measured by Vancouver Scar Scale. The scale is based on four values: pliability, height, vascularity and pigmentation. The four categories are given a score between 0 and 4. The scale will be evaluated by a surgeon and a nurse who do not know the type of dressing one month after discharge from the hospital. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Ghodrat Allah Naseh
Surgery ward, Emam Reza Educational Hospital, Birjand University of Medical Sciences
Outcome results
None listed